Skip to main content Skip to main menu
UF Health University of Florida
College of Pharmacy UNIVERSITY of FLORIDA
Apply to Pharm.D. Program
Leslie Hendeles

Leslie Hendeles, Pharm.D.

Professor Emeritus

Department: MD-PEDIATRICS
Business Phone: (352) 377-0954
Business Email: hendeles@cop.ufl.edu
CV: View Curriculum Vitae

On This Page

About Leslie Hendeles

Dr. Hendeles is a Professor Emeritus in the College of Pharmacy and also in the Department of Pediatrics at the University of Florida. Among his current research interests are the improvement of adherence to asthma medications and delivery of inhaled drugs to young children. He is a consultant to FDA’s Pulmonary Division, and previously served on the Coordinating Committee of NIH’s Asthma Education Program, as well as CDC’s Expert Panel on Asthma Guidelines for Emergency Medical Services. Dr. Hendeles provides advice on drug therapy and teaches in the Pediatric Pulmonary Clinic at the University of Florida.

Teaching Profile

Courses Taught

  1. PHA5782 – Pharmacotherapy 2

    College of Pharmacy

  2. PHA5108L – Pharmaceu Skls Lab 1

    College of Pharmacy

  3. PHA5907 – Research in Phar Prac

    College of Pharmacy

  4. PHA3931 – Honors Seminar in Pharmaceutical Research: In Search of Magic Bullets

    College of Pharmacy

  5. PHA5890 – Intro Women’S Health

    College of Pharmacy

Clinical Profile

clinical pharmacology of drugs for asthma and allergic rhinitis

Publications

Academic Articles

Grants

  1. A Three-week, Multicenter, Randomized, Double-blind, Placebo-controlled, Chronic-dose Safety and Efficacy Study of Albuterol Mulit-dose Dry Powder Inhaler (MDPI) Relative to Placebo in Pediatric Asmathics

    Role:
    Principal Investigator
    Funding:
    PHARMACEUTICAL RES ASSO via TEVA PHARMACEUTICALS USA

  2. A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination with an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients with Persistent Asthma

    Role:
    Principal Investigator
    Funding:
    NOVARTIS PHARMACEUTICALS CORP

  3. A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/Salmeterol Combination versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old with Persistent Asthma

    Role:
    Principal Investigator
    Funding:
    PAREXEL INTERNATIONAL PTY via GLAXOSMITHKLINE

  4. 02013155

    Role:
    Principal Investigator
    Funding:
    UF RESEARCH FOU MISC

Education

  1. Pharm.D. , clinical pharmacy

    University of Southern California

Contact Details

Phones:
Business:
(352) 377-0954
Emails:
Business:
hendeles@cop.ufl.edu
Addresses:
Business Mailing:
3549 NW 30TH BLVD
 GAINESVILLE FL 32605